17β-Estradiol and the phytoestrogen genistein attenuate neuronal apoptosis induced by the endoplasmic reticulum calcium-ATPase inhibitor thapsigargin

Nancy J. Linford, Daniel Dorsa

Research output: Contribution to journalArticle

110 Citations (Scopus)

Abstract

Estrogenic compounds have been shown to protect neurons from a variety of toxic stimuli in vitro and in vivo and depletion of estrogen at menopause has been associated with increased risk of neurodegenerative diseases. Genistein is an isoflavone soy derivative that binds to estrogen receptors with selective estrogen receptor modulator (SERM) properties. Recent FDA recommendations of soy intake for cholesterol reduction have prompted investigation into the potentially estrogenic role of dietary soy phytochemicals in the brain. In this study, we have shown that 50nM genistein significantly reduces neuronal apoptosis in an estrogen receptor-dependent manner. The importance of apoptosis in the brain has been recognized with regard to organization of the developing brain as well as degeneration in response to disease or stroke; however, the effects of estrogenic compounds on neuronal apoptosis have not been thoroughly examined. We developed a model of apoptotic toxicity in primary cortical neurons by using the endoplasmic reticulum (ER) calcium-ATPase inhibitor, thapsigargin, to test potential anti-apoptotic effects of 17β-estradiol and genistein. Estrogen receptor β, but not estrogen receptor α, was detected in our primary neuron cultures. Thapsigargin-induced apoptosis was confirmed by loss of mitochondrial function, DNA laddering, nuclear condensation and fragmentation, and caspase activation. Both 17β-estradiol and genistein reduced the number of apoptotic neurons and reduced the number of neurons containing active caspase-3. This effect was blocked by co-addition of ICI 182,780. Our results demonstrate that genistein and 17β-estradiol have comparable anti-apoptotic properties in primary cortical neurons and that these properties are mediated through estrogen receptors.

Original languageEnglish (US)
Pages (from-to)1029-1040
Number of pages12
JournalSteroids
Volume67
Issue number13-14
DOIs
StatePublished - Dec 2002
Externally publishedYes

Fingerprint

Phytoestrogens
Thapsigargin
Calcium-Transporting ATPases
Genistein
Endoplasmic Reticulum
Neurons
Estradiol
Estrogen Receptors
Apoptosis
Brain
Estrogens
Neurodegenerative diseases
Selective Estrogen Receptor Modulators
Isoflavones
Poisons
Phytochemicals
Menopause
Caspases
Mitochondrial DNA
Caspase 3

Keywords

  • Apoptosis
  • Estrogen
  • Genistein
  • Neuroprotection
  • Phytoestrogen
  • Thapsigargin

ASJC Scopus subject areas

  • Biochemistry
  • Endocrinology
  • Molecular Biology

Cite this

17β-Estradiol and the phytoestrogen genistein attenuate neuronal apoptosis induced by the endoplasmic reticulum calcium-ATPase inhibitor thapsigargin. / Linford, Nancy J.; Dorsa, Daniel.

In: Steroids, Vol. 67, No. 13-14, 12.2002, p. 1029-1040.

Research output: Contribution to journalArticle

@article{86925f4c0fb041c9ae457ef008f9fe30,
title = "17β-Estradiol and the phytoestrogen genistein attenuate neuronal apoptosis induced by the endoplasmic reticulum calcium-ATPase inhibitor thapsigargin",
abstract = "Estrogenic compounds have been shown to protect neurons from a variety of toxic stimuli in vitro and in vivo and depletion of estrogen at menopause has been associated with increased risk of neurodegenerative diseases. Genistein is an isoflavone soy derivative that binds to estrogen receptors with selective estrogen receptor modulator (SERM) properties. Recent FDA recommendations of soy intake for cholesterol reduction have prompted investigation into the potentially estrogenic role of dietary soy phytochemicals in the brain. In this study, we have shown that 50nM genistein significantly reduces neuronal apoptosis in an estrogen receptor-dependent manner. The importance of apoptosis in the brain has been recognized with regard to organization of the developing brain as well as degeneration in response to disease or stroke; however, the effects of estrogenic compounds on neuronal apoptosis have not been thoroughly examined. We developed a model of apoptotic toxicity in primary cortical neurons by using the endoplasmic reticulum (ER) calcium-ATPase inhibitor, thapsigargin, to test potential anti-apoptotic effects of 17β-estradiol and genistein. Estrogen receptor β, but not estrogen receptor α, was detected in our primary neuron cultures. Thapsigargin-induced apoptosis was confirmed by loss of mitochondrial function, DNA laddering, nuclear condensation and fragmentation, and caspase activation. Both 17β-estradiol and genistein reduced the number of apoptotic neurons and reduced the number of neurons containing active caspase-3. This effect was blocked by co-addition of ICI 182,780. Our results demonstrate that genistein and 17β-estradiol have comparable anti-apoptotic properties in primary cortical neurons and that these properties are mediated through estrogen receptors.",
keywords = "Apoptosis, Estrogen, Genistein, Neuroprotection, Phytoestrogen, Thapsigargin",
author = "Linford, {Nancy J.} and Daniel Dorsa",
year = "2002",
month = "12",
doi = "10.1016/S0039-128X(02)00062-4",
language = "English (US)",
volume = "67",
pages = "1029--1040",
journal = "Steroids",
issn = "0039-128X",
publisher = "Elsevier Inc.",
number = "13-14",

}

TY - JOUR

T1 - 17β-Estradiol and the phytoestrogen genistein attenuate neuronal apoptosis induced by the endoplasmic reticulum calcium-ATPase inhibitor thapsigargin

AU - Linford, Nancy J.

AU - Dorsa, Daniel

PY - 2002/12

Y1 - 2002/12

N2 - Estrogenic compounds have been shown to protect neurons from a variety of toxic stimuli in vitro and in vivo and depletion of estrogen at menopause has been associated with increased risk of neurodegenerative diseases. Genistein is an isoflavone soy derivative that binds to estrogen receptors with selective estrogen receptor modulator (SERM) properties. Recent FDA recommendations of soy intake for cholesterol reduction have prompted investigation into the potentially estrogenic role of dietary soy phytochemicals in the brain. In this study, we have shown that 50nM genistein significantly reduces neuronal apoptosis in an estrogen receptor-dependent manner. The importance of apoptosis in the brain has been recognized with regard to organization of the developing brain as well as degeneration in response to disease or stroke; however, the effects of estrogenic compounds on neuronal apoptosis have not been thoroughly examined. We developed a model of apoptotic toxicity in primary cortical neurons by using the endoplasmic reticulum (ER) calcium-ATPase inhibitor, thapsigargin, to test potential anti-apoptotic effects of 17β-estradiol and genistein. Estrogen receptor β, but not estrogen receptor α, was detected in our primary neuron cultures. Thapsigargin-induced apoptosis was confirmed by loss of mitochondrial function, DNA laddering, nuclear condensation and fragmentation, and caspase activation. Both 17β-estradiol and genistein reduced the number of apoptotic neurons and reduced the number of neurons containing active caspase-3. This effect was blocked by co-addition of ICI 182,780. Our results demonstrate that genistein and 17β-estradiol have comparable anti-apoptotic properties in primary cortical neurons and that these properties are mediated through estrogen receptors.

AB - Estrogenic compounds have been shown to protect neurons from a variety of toxic stimuli in vitro and in vivo and depletion of estrogen at menopause has been associated with increased risk of neurodegenerative diseases. Genistein is an isoflavone soy derivative that binds to estrogen receptors with selective estrogen receptor modulator (SERM) properties. Recent FDA recommendations of soy intake for cholesterol reduction have prompted investigation into the potentially estrogenic role of dietary soy phytochemicals in the brain. In this study, we have shown that 50nM genistein significantly reduces neuronal apoptosis in an estrogen receptor-dependent manner. The importance of apoptosis in the brain has been recognized with regard to organization of the developing brain as well as degeneration in response to disease or stroke; however, the effects of estrogenic compounds on neuronal apoptosis have not been thoroughly examined. We developed a model of apoptotic toxicity in primary cortical neurons by using the endoplasmic reticulum (ER) calcium-ATPase inhibitor, thapsigargin, to test potential anti-apoptotic effects of 17β-estradiol and genistein. Estrogen receptor β, but not estrogen receptor α, was detected in our primary neuron cultures. Thapsigargin-induced apoptosis was confirmed by loss of mitochondrial function, DNA laddering, nuclear condensation and fragmentation, and caspase activation. Both 17β-estradiol and genistein reduced the number of apoptotic neurons and reduced the number of neurons containing active caspase-3. This effect was blocked by co-addition of ICI 182,780. Our results demonstrate that genistein and 17β-estradiol have comparable anti-apoptotic properties in primary cortical neurons and that these properties are mediated through estrogen receptors.

KW - Apoptosis

KW - Estrogen

KW - Genistein

KW - Neuroprotection

KW - Phytoestrogen

KW - Thapsigargin

UR - http://www.scopus.com/inward/record.url?scp=0036889192&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036889192&partnerID=8YFLogxK

U2 - 10.1016/S0039-128X(02)00062-4

DO - 10.1016/S0039-128X(02)00062-4

M3 - Article

C2 - 12441188

AN - SCOPUS:0036889192

VL - 67

SP - 1029

EP - 1040

JO - Steroids

JF - Steroids

SN - 0039-128X

IS - 13-14

ER -